IONS
Ionis Pharmaceuticals Inc
$78.64
1.40 (1.74%) Today
0.65 (0.82%) After-hours
— up— down
Market Cap
$13.10B+100.7%
Revenue (TTM)
$1.06B+47.4%
Net Income (TTM)
$-347,244,312
$-347,244,312EPS (TTM)
-2.10
-2.10Shares Out
165.26M
165.26MOpen
$81.17
$81.17Previous Close
$80.69
$80.69Day Range
$79.21 – $81.24
$79.21 – $81.2452-Week Range
$39.72 – $86.74
$39.72 – $86.74Beta
0.36
0.36Volume
2.04M
2.04MAvg Volume
2.04M
2.04MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout IONS
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.
Related
News
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow
SeekingAlpha · 5d ago
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction Transcript
SeekingAlpha · 5d ago
Goldman Sachs Maintains Neutral on Ionis Pharmaceuticals, Raises Price Target to $75
Benzinga · 5d ago
Ionis Climbs As FDA Clears New Therapy To Lower Triglycerides, Pancreatitis Risk
Benzinga · 5d ago
Leerink Partners Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $129
Benzinga · 5d ago